Brachytherapy for prostate cancer: Is the pretreatment prostate volume important?

BJU International

Volumn 102, Issue 11, 2008, Pages 1585-1588

  Meyer, Jon Paul ^a,b   Bell, C Richard W ^b   Elwell, Christine ^b   Kunkler, Roger B ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; Cancer; IPSS; Prostate volume; PSA

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SYMPTOM; URINE RETENTION;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; PROSTATISM; TREATMENT OUTCOME;

EID: 56649102492     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07874.x     Document Type: Article

References (17)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999 49 : 8 31
2. Stock GS, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995 32 : 219 25
3. Bard Inc. Real Time Ultrasound-Guided Prostate Seed Implantation Procedure Manual. ProSeed, 1999
4. Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostate hyperplasia. J Urol 1992 148 : 1549 57
5. EAU. Available at: http://www.uroweb.nl/files/uploaded_files/ 2005ProstateCancer.pdf. Accessed May 2008
6. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000 57 : 315 21
7. Merrick GS, Butler WM, Galbreath RW, Lief JM, Adamovich E. Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy. Urology 2002 60 : 98 103
8. Grimm P, Heaney C, Sylvester J, Blasko J. Prostate seed implantation for prostate cancer. Prostate Cancer Res Inst 2003 6 : 1 19
9. Arterbery VE, Wallner K, Roy J, Fuks Z. Short-term morbidity from CT planned transperineal I-125 prostate implants. Int J Radiat Oncol Biol Phys 1993 25 : 661 7
10. Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996 23 : 633 49
11. Grier D. Complications of permanent seed implantation. J Brachytherapy Int 2001 17 : 205 10
12. Terk M, Stock R, Stone N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998 160 : 1379 82
13. Lee N, Wuu C, Brody R et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000 48 : 1457 60
14. Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S. Urinary morbidity following ultrasound guided transperineal seed implantation. Int J Radiat Oncol Biol Phys 1999 45 : 59 67
15. Crook J, McLean M, Catton C, Yeung I, Tsihlias J, Pintilie M. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 2002 52 : 453 60
16. Blasko JC, Ragde H, Grimm PD. Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 1991 137 : 113 8
17. Sylvester JE, Grimm P, Blasko J, Meier RM, Heaney CT, Cavanagh W. Transperineal permanent brachytherapy for local recurrence following external beam radiation for early-stage prostate cancer. J Brachyther Int 2001 17 : 181 8